作者：
Jabbour,E. [1]
;
LeCoutre,P.D. [2]
;
Cortes,J. [3]
;
Giles,F. [4]
;
Bhalla,K.N. [5]
;
Pinilla-Ibarz,J. [6]
;
Larson,R.A. [7]
;
Gattermann,N. [8]
;
Ottmann,O.G. [9]
;
Hochhaus,A. [10]
;
Hughes,T.P. [11]
;
Saglio,G. [12]
;
Radich,J.P. [13]
;
Kim,D.-W. [14]
;
Martinelli,G. [15]
;
Reynolds,J. [16]
;
Woodman,R.C. ;
Baccarani,M. ;
Kantarjian,H.M.
作者单位：
University of Chicago, Chicago, IL, United States
[1]
Medizinische Klinik II, Johann Wolfgang Goethe-University, Frankfurt, Germany
[2]
Klinik für Innere Medizin II, Abteilung H?matologie/Onkologie, Universit?tsklinikum Jena, Jena
[3]
Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States
[4]
Heinrich-Heine-Universitat, Düsseldorf, Germany
[5]
Division of Internal Medicine and Hematology, University of Turin, Orbassano, Italy
[6]
HRB Clinical Research Facility, National University of Ireland Galway and Trinity College Dublin
[7]
Department of Leukemia, MD Anderson Cancer Center, University of Texas, 1515 Holcombe Boulevard
[8]
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
[9]
Seoul St Mary's Hospital, Catholic University of Korea, Seoul, South Korea
[10]
Novartis Pharma AG, Basel, Switzerland
[11]
Kansas University Medical Center, University of Kansas Cancer Center, Kansas City, KS, United States
[12]
Institute of Hematology L. e A. Seràgnoli, University of Bologna, Bologna, Italy
[13]
Malignant Hematology Division, H Lee Moffitt Cancer Center, Tampa, FL, United States
[14]
Medizinische Klinik M.S. H?matologie und Onkologie, Charité-University of Medicine Berlin, Berlin
[15]
Royal Adelaide Hospital, SA Pathology, Adelaide, SA, Australia
[16]
发布时间
2013-11-20
换一批
